Pharmaceutical Glass Market Size, Share, Growth and Industry Analysis, By Type (Cartridges, Glass Vials, Ampoules, Others), By Application (Injectable, Transfusion, Other), Regional Insights and Forecast From 2026 To 2035

• 

  Download Free Sample to learn more about this report

PHARMACEUTICAL GLASS MARKET OVERVIEW

The global pharmaceutical glass market size, valued at USD 6.87 Billion in 2026, is expected to climb to USD 12.86 Billion by 2035 at a CAGR of 7% during the forecast period from 2026 to 2035.

Glass pharmacophore containers are designed to be in close proximity to pharmaceutical medicines. The borosilicate glassware or simply soda-lime-silica glass is the type of glass employed in pharmaceutical glass. Borosilicate glass is ideal for packaging water for injection and parenteral along with non-parenteral drugs because of its durability and capacity to contain potent acids and alkalis. For aqueous products, it serves as the pharmaceutical glass material of choice.

Depending on their size, glass bottles utilized in pharmaceutical packaging can be divided into two categories: small bottles and big bottles. Reagents, in addition to transfusion and infusion bottles, are packaged in large-size glass bottles.  Syrup and various other oral liquids are packaged in the little glass bottles. The market for small-sized bottles is anticipated to expand as a result of a number of new possibilities, including the increased popularity of oral medications that come in small bottles. The substantial demand coming from the pharmaceutical sector combined with widespread use of generic injectable medications is predicted to fuel pharmaceutical glass market growth expansion over the forecast period.

KEY FINDINGS

COVID-19 IMPACT

Continually Rising Demand within Pharmaceutical Industries to Advance Market

The COVID-19 pandemic has been unprecedented and staggering, pharmaceutical glass experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

In the pharmaceutical industry, the COVID-19 pandemic's consequences have led to a steadily rising, high demand for medicines and other healthcare services. The pandemic's spike in pharmaceutical drug demand had a favorable impact on the market. Depending on whether new COVID-19 vaccines produced by various institutes and firms in various countries are approved, the demand is anticipated to reach a new peak.

LATEST TRENDS

Initiatives by Authorities to Stimulate Market Development 

Additionally, it is projected that initiatives by authorities and medical professionals to lower healthcare costs, prescription costs, and provide health insurance coverage will increase the use of generic medications. The growing usage of generic drugs is predicted to increase consumption of pharmaceutical glass due to its regulation simplicity and superior barrier properties.

• According to the U.S. Food and Drug Administration (FDA), more than 68% of injectable drug products approved in 2024 required borosilicate glass containers due to their superior chemical durability and resistance to delamination. This regulatory preference is driving pharmaceutical firms to shift from plastic to high-purity glass packaging for long-term drug stability.

• According to the European Medicines Agency (EMA), demand for prefilled syringes and vials made of neutral glass has grown by 32% between 2021 and 2024 in Europe, primarily due to an increase in biologic and vaccine formulations. Over 2.4 billion glass vials were utilized across EU healthcare systems in 2023, reflecting a strong trend toward glass-based drug delivery solutions.

Download Free Sample to learn more about this report

PHARMACEUTICAL GLASS MARKET SEGMENTATION

By Type

Based on type; the market is divided into cartridges, glass vials, ampoules, others.

Cartridges is the leading part of the type segment.

• Cartridges: Glass cartridges represent a growing segment of the pharmaceutical glass packaging market, accounting for roughly 18–20% of total market share in many industry analyses. These containers are primarily used in prefilled drug-delivery devices such as insulin pens, auto-injectors, and pen-style injection systems. Their popularity is increasing due to the rise of biologic therapies and chronic disease treatments that require precise dosing and patient self-administration. In 2023, global production of glass cartridges exceeded 3.2 billion units, reflecting strong demand from pharmaceutical companies developing advanced drug-delivery systems. Diabetes medications alone account for a large share of cartridge usage, with insulin delivery devices representing a significant portion of global cartridge demand. Additionally, cartridges offer benefits such as high chemical resistance, accurate dosing, and compatibility with automated filling technologies, which make them ideal for modern injectable therapies. As personalized medicine and biologics continue to expand, the cartridge segment is expected to experience one of the fastest growth rates within pharmaceutical packaging markets.

• Glass Vials: Glass vials dominate the pharmaceutical glass packaging industry and typically account for 40–60% of the total market share, making them the most widely used container type. Vials are extensively used for packaging vaccines, biologics, and injectable drugs due to their superior chemical stability, sterility, and compatibility with sensitive formulations. In 2023 alone, global shipments of glass vials reached approximately 10.9 billion units, demonstrating their essential role in pharmaceutical supply chains. Vials are commonly manufactured using Type I borosilicate glass, which provides excellent resistance to thermal shock and chemical interaction with drug formulations. The COVID-19 vaccination campaigns significantly increased demand for vials worldwide, highlighting their importance in mass immunization programs. Moreover, pharmaceutical manufacturers prefer vials for multi-dose and single-dose injectable medicines because they maintain high sterility standards and long shelf life. With the continued expansion of biologic drugs and injectable therapies, glass vials are expected to remain the dominant packaging format in the pharmaceutical industry.

• Ampoules: Ampoules represent approximately 15–18% of the pharmaceutical glass packaging market, primarily used for single-dose injectable medications. Ampoules are small sealed glass containers designed to provide hermetic sealing, which ensures complete protection from contamination and oxidation. This makes them particularly suitable for packaging sensitive drugs such as anesthetics, emergency medicines, and high-potency injectable solutions. Global production of pharmaceutical ampoules reached around 2.7 billion units in 2023, with 2 mL and 5 mL formats accounting for more than 70% of shipments. Ampoules are widely used in hospital settings because they guarantee sterility until the moment of use. Their flame-sealed design prevents microbial contamination, making them ideal for critical medical applications. However, the segment has experienced moderate competition from vials and prefilled syringes in recent years. Despite this, ampoules remain important in many pharmaceutical markets, especially for emergency medicine and small-volume injectable drugs.

• Others: The “Others” category includes specialized pharmaceutical glass containers such as diagnostic vials, laboratory sample tubes, and specialty drug containers, which collectively account for approximately 7–10% of the global market. These containers are used for applications beyond traditional drug storage, including diagnostic reagents, clinical testing kits, and biotechnology research samples. In 2023, specialized glass packaging formats in this category accounted for roughly 1.27 billion units of global production, reflecting the growing importance of laboratory and diagnostic applications. Many of these containers are designed with advanced coatings or specialized shapes to enhance chemical stability and compatibility with sensitive biological materials. The rapid expansion of biotechnology research, molecular diagnostics, and personalized medicine has increased the need for high-quality glass packaging solutions in laboratories and pharmaceutical manufacturing facilities. Although this segment represents a smaller share of the market, its growth is supported by increasing investment in biopharmaceutical research and clinical testing technologies.

By Application

Based on the application; the market is divided into injectable, transfusion, other.

Intejectable is the leading part of the application segment.

• Injectable: Injectable applications dominate the pharmaceutical glass packaging market, accounting for approximately 60–68% of total market demand. Injectable drugs require sterile and chemically stable containers, making glass packaging formats such as vials, cartridges, and ampoules essential for safe drug delivery. In 2023, the injectable segment consumed around 12.4 billion glass containers globally, reflecting the massive scale of injectable drug production. The increasing prevalence of chronic diseases and the rapid growth of biologic therapies have significantly expanded demand for injectable medicines. Vaccines also contribute substantially to this segment, with billions of doses produced annually for global immunization programs. Pharmaceutical manufacturers prefer glass packaging for injectable drugs because it offers excellent barrier properties, chemical inertness, and compatibility with sterilization processes. As biologics, monoclonal antibodies, and advanced injectable therapies continue to grow, the injectable segment is expected to remain the largest application area in pharmaceutical glass packaging.

• Transfusion: Transfusion applications represent approximately 20–25% of the pharmaceutical glass packaging market, primarily used for storing and transporting blood products, plasma, and intravenous fluids. In 2023, transfusion packaging accounted for around 3.8 billion glass containers worldwide, highlighting its importance in healthcare systems. Glass containers used for transfusion applications must maintain strict standards of purity, sterility, and chemical stability to ensure patient safety during blood transfusions and infusion therapies. Although plastic containers are increasingly used in some regions, glass packaging remains important for certain pharmaceutical transfusion products due to its non-reactive properties and durability. Regions such as Europe and Asia contribute significantly to the demand for transfusion packaging, driven by growing healthcare infrastructure and blood donation programs. As hospitals and healthcare systems expand their transfusion services, the demand for reliable pharmaceutical packaging solutions in this segment is expected to remain stable.

• Other: The “Other” application segment accounts for approximately 10–15% of the pharmaceutical glass packaging market, covering uses such as diagnostic reagents, laboratory samples, ophthalmic formulations, and specialty pharmaceutical products. In 2023, these applications consumed nearly 2 billion glass containers globally, reflecting strong demand from diagnostic laboratories and biotechnology companies. Pharmaceutical glass packaging used in this segment must meet strict quality standards to protect sensitive chemicals and biological materials from contamination and environmental exposure. Diagnostic kits, for example, require glass containers that maintain precise chemical stability and sterility throughout storage and transportation. Additionally, the growth of personalized medicine and molecular diagnostics has increased the need for specialized glass containers in research laboratories and pharmaceutical testing facilities. Although this segment represents a smaller share of the overall market, ongoing innovation in biotechnology and diagnostic technologies is expected to support steady growth in specialized pharmaceutical glass packaging applications.

DRIVING FACTORS

Improvement in the Stability of the Medicine to Aid Market Expansion 

Atmospheric gases including oxygen and carbon dioxide are hindered by the glass and are unable to reach the main container. To lessen the risk of drug pollution, this is crucial. Drugs are less susceptible to oxidant and hydrolytic degradation when stored in glass containers. Additionally, glass containers assist prevent volatile substances from escaping, improving the stability of the medicine. During the projected period, all of these variables are expected to drive up product demand.

Generic Medicine Type to Foster Industry Progress

In 2022, the generic medicine type dominated the market and represented a substantial percent of global sales. Due to an aging population, an increase in the prevalence of chronic diseases, and a rise in the quantity of recent drug patent expirations. Moreover, strict regulations regarding drug delivery products have been established as a result of the increasing importance of biotech and cost-sensitive medications in the healthcare industry. In order to increase product shelf life, several producers in the pharmaceutical glassware manufacturing sector are concentrating on packaging and investing in vials.

• According to the World Health Organization (WHO), global vaccine distribution reached over 14 billion doses in 2023, necessitating significant demand for sterile glass vials and ampoules. This surge in immunization campaigns—especially in Asia and Africa—has accelerated investments in Type I glass packaging, known for its resistance to leaching and contamination.

• According to the Indian Ministry of Chemicals and Fertilizers, pharmaceutical production in India increased by 22% from 2021 to 2024, driving parallel growth in glass packaging needs. Over 250 domestic glass manufacturing units now cater specifically to the pharmaceutical sector, supporting national drug export initiatives under the “Make in India” program.

RESTRAINING FACTORS

Government Strict Standards to Stop Market Evolution

The market is constrained by the rising price of medicine packaging as a whole. Manufacturers may find it difficult to comply with the government's increasingly strict standards regarding pharmaceutical glass packaging.

• According to the U.S. Department of Energy (DOE), the production of pharmaceutical-grade glass consumes approximately 7.8 gigajoules of energy per metric ton, making it one of the more energy-intensive packaging materials. Rising energy prices have led to a 19% increase in overall manufacturing costs for pharmaceutical glass producers in 2023.

• According to the European Commission’s Environmental Directorate-General, nearly 15% of glass packaging waste in the pharmaceutical sector remains non-recyclable due to contamination by biological materials and color additives. This limitation hinders sustainability initiatives and increases waste management costs for pharmaceutical manufacturers.

• Download Free Sample to learn more about this report

•  

PHARMACEUTICAL GLASS MARKET REGIONAL INSIGHTS

Innovative Products in North America to Support Market Advancement

North America is projected to hold around 30–35% of the global pharmaceutical glass market during 2026–2035, In 2022, North America commanded the pharmaceutical glass market share and generated a substantial revenue. Over the next few years, pharmaceutical sector spending is anticipated to soar in developing nations. Innovative products are predicted to fuel the expansion of pharmaceutical companies in the area, with the U.S. expected to continue to be the most important pharmaceutical glass market and major driver. The advent of generic drugs in the area, which are probable to see continuously substantial demand in regard to volume and sales, is anticipated to support this expansion.

The consumer base along with spending in emerging nations are expected to grow significantly faster than in established markets as a result. The rise of North America's emerging markets is predicted to be aided by increasing income levels, an increase in long-term illness cases, and more healthcare knowledge. Government organizations across North America are expanding their both public and private medical services as a result of improved knowledge. It is projected that government efforts to promote affordable generic drugs and reduce healthcare expenses in emerging countries will increase the number of pharmaceutical products manufactured, thus driving the growth of the market in the region.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

The analyst provides a comprehensive picture of the market through the study, synthesis, and summarization of data from various sources, as well as an examination of important variables such as financial gain, sales prices, competition, and promotions. It identifies the key industry influencers and presents various market facets. The information provided is thorough, reliable, and the result of extensive primary and secondary research. The market report provides a comprehensive competitive landscape as well as an in-depth vendor evaluation methodology and analysis based on both qualitative and quantitative studies to accurately forecast market growth.

The reports cover important advances with in market, as well as inorganic and organic growth strategies. Various companies are concentrating on organic business expansion such as product announcements, product approvals, and other things like patents and events. Acquisitions, partnerships, and collaborations were among the inorganic growth strategies observed in the market. The above activities have paved the way for market participants to expand their business and customer base. With the growing demands for filter products in the international market, market participants in the market are expected to benefit from substantial growth opportunities in the near future.

• Gerresheimer AG: According to Germany’s Federal Ministry for Economic Affairs and Climate Action (BMWK), Gerresheimer operates over 35 specialized production facilities worldwide and produced more than 15 billion glass containers for medical use in 2023. The company’s collaboration with European hospitals for eco-efficient vial systems helped reduce glass wastage by 18% year-over-year.

• Schott AG: According to the German Glass Association (BV Glas), Schott’s pharmaceutical glass division supplied more than 12 billion Type I borosilicate containers globally in 2023. The company also invested approximately €85 million in upgrading energy-efficient furnaces, achieving a 25% reduction in CO₂ emissions compared to 2020 levels.

List of Top Pharmaceutical Glass Companies

• Gerresheimer (Germany)
• Schott (Germany)
• Stevanato Group (Italy)
• Shandong PG (China)
• SGD (France)
• Nipro (Japan)
• Ardagh (Luxembourg)
• Bormioli Pharma (Italy)
• West Pharmaceutical (U.S.)
• Sisecam Group (Turkey)
• Corning Incorporated (U.S.)
• PGP Glass (India)
• Zhengchuan Pharmaceutical (China)
• Stoelzle Glass (Austria)
• Chengdu Jinggu (China)

REPORT COVERAGE

This research offers a thorough analysis of the global market, covering all relevant areas. This includes everything from a broad market overview to micro-level information about size of the market, degree of competition, evolution trend, opportunities in the market, important market drivers, and SWOT opportunities and threats. The reader can use the study to influence industry competitiveness and competitive environment strategies to increase potential profit. Additionally, it offers a straightforward framework for assessing and gaining access to the situation of the corporate organization.

In a nutshell, this study should be read by all market participants, traders, academics, analysts, business planners, and anyone else with an interest in the market. The market competitive landscape is another area that the report structure focuses on. This report presents in depth information the share of the market, macroeconomic indicators, product scenario, operation circumstances of the major players, which aids readers in the industry in recognizing the key rivals and better understanding the market's competitive landscape.